{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:46:30Z","timestamp":1780393590644,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s11886-024-02121-7","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T08:02:06Z","timestamp":1724659326000},"page":"1265-1271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Echocardiography in Systemic Lupus Erythematosus"],"prefix":"10.1007","volume":"26","author":[{"given":"Mohammed Z.","family":"Al-Zahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Leung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"issue":"17","key":"2121_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480\u201391. https:\/\/doi.org\/10.1001\/jama.2024.2315.","journal-title":"JAMA"},{"key":"2121_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","volume":"40","author":"JJ Miner","year":"2014","unstructured":"Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am. 2014;40:51\u201360. https:\/\/doi.org\/10.1016\/j.rdc.2013.10.003.","journal-title":"Rheum Dis Clin N Am"},{"key":"2121_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","volume":"14","author":"A Doria","year":"2005","unstructured":"Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14:683\u20136. https:\/\/doi.org\/10.1191\/0961203305lu2200oa.","journal-title":"Lupus"},{"key":"2121_CR4","unstructured":"Rao RV, Chan KL. Systemic Lupus Erythematosus in: ASE\u2019S Comprehensive Echocardiograhy, Second Edition, an imprint of Elsevier Inc. 2016:757\u2013760."},{"key":"2121_CR5","doi-asserted-by":"publisher","unstructured":"Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum. 2013;43(1):77\u201395. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.12.002.","DOI":"10.1016\/j.semarthrit.2012.12.002"},{"key":"2121_CR6","doi-asserted-by":"publisher","unstructured":"Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc. 1999;74:275\u2013284. https:\/\/doi.org\/10.4065\/74.3.275.","DOI":"10.4065\/74.3.275"},{"key":"2121_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/0002-9149(90)90329-Y","volume":"65","author":"IG Crozier","year":"1990","unstructured":"Crozier IG, Li E, Milne M, Gary Nicholls M. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol. 1990;65:1145\u20138.","journal-title":"Am J Cardiol"},{"issue":"14","key":"2121_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1177\/0961203311420318","volume":"20","author":"J Bourr\u00e9-Tessier","year":"2011","unstructured":"Bourr\u00e9-Tessier J, Huynh T, Clarke AE, Bernatsky S, Joseph L, Belisle P, Pineau CA. Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus. 2011;20(14):1518\u201325. https:\/\/doi.org\/10.1177\/0961203311420318.","journal-title":"Lupus"},{"key":"2121_CR9","unstructured":"Roldan CA, Qualls CR, Sopko KS, et al. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol. 2008;35:224\u20139."},{"key":"2121_CR10","doi-asserted-by":"publisher","unstructured":"Cauduro AS, Moder KG, Tsang TS, Seward JB. Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus. Am J Cardiol. 2003;92:1370\u20131372. https:\/\/doi.org\/10.1016\/j.amjcard.2003.08.036.","DOI":"10.1016\/j.amjcard.2003.08.036"},{"key":"2121_CR11","doi-asserted-by":"publisher","unstructured":"Maharaj S, Chang S. Pericardial effusions in systemic lupus erythematosus \u2014 Who is most likely to develop tamponade? Int J Cardiol. 2015;180:149\u2013150. https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.191.","DOI":"10.1016\/j.ijcard.2014.11.191"},{"key":"2121_CR12","doi-asserted-by":"publisher","unstructured":"Bilal A, Sulemankhil I, Chauhan R. et al. \u201cBreaking Muscles and Hearts\u201d: Rhabdomyolysis and Pericardial Tampondate as Initial Manifestations of Systemic Lupus Erythematosuc. JACC. 2024;83(13_Supplement):3995. https:\/\/doi.org\/10.1016\/S0735-1097(24)05985-0.","DOI":"10.1016\/S0735-1097(24)05985-0"},{"key":"2121_CR13","doi-asserted-by":"publisher","unstructured":"Shalomi A, Ramesh R. Pericardial Effusion as the Initial Presentation of Systemic Lupus Erythematosus in a 37-Year-Old Female. Cureus. 2023;15(11):e49080. https:\/\/doi.org\/10.7759\/cureus.49080.","DOI":"10.7759\/cureus.49080"},{"key":"2121_CR14","doi-asserted-by":"publisher","unstructured":"Creed K, Randhawa N, Siddiqui S, Wichmann A, Test V. Pericardial Effusion in a Middle Aged Woman as Initial Presentation of Systemic of Systemic Lupus Erythematous. CHEST. 160(4):A13. https:\/\/doi.org\/10.1016\/j.chest.2021.07.069.","DOI":"10.1016\/j.chest.2021.07.069"},{"key":"2121_CR15","doi-asserted-by":"publisher","unstructured":"Doherty N, Siegel R. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257\u201365. https:\/\/doi.org\/10.1016\/0002-8703(85)90023-7.","DOI":"10.1016\/0002-8703(85)90023-7"},{"key":"2121_CR16","doi-asserted-by":"publisher","unstructured":"Pieretti J. Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass. Circulation. 116(4). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.673319.","DOI":"10.1161\/CIRCULATIONAHA.106.673319"},{"issue":"9","key":"2121_CR17","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.echo.2020.04.018","volume":"33","author":"T Gegenava","year":"2020","unstructured":"Gegenava T, Gegenava M, Steup-Beekman GM, Huizinga TWJ, Bax JJ, Delgado V, Marsan NA. Left ventricular systolic function in patients with systemic Lupus Erythematosus and its Association with Cardiovascular events. J Am Soc Echocardiogr. 2020;33(9):1116\u201322. https:\/\/doi.org\/10.1016\/j.echo.2020.04.018.","journal-title":"J Am Soc Echocardiogr"},{"key":"2121_CR18","doi-asserted-by":"crossref","unstructured":"Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(2):338\u201346.","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U"},{"issue":"8","key":"2121_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jacc.2011.12.060","volume":"60","author":"S Abbasi","year":"2012","unstructured":"Abbasi S, Tarter L, Farzaneh-Far R, Farzaneh-Far A. Hydroxychloroquine: a treatable cause of cardiomyopathy. J Am Coll Cardiol. 2012;60(8):786. https:\/\/doi.org\/10.1016\/j.jacc.2011.12.060.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2121_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJM198809293191302","volume":"319","author":"E Galve","year":"1988","unstructured":"Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med. 1988;319(13):817\u201323. https:\/\/doi.org\/10.1056\/NEJM198809293191302.","journal-title":"N Engl J Med"},{"issue":"7","key":"2121_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","volume":"120","author":"I Moyssakis","year":"2007","unstructured":"Moyssakis I, Tektonidou M, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos H. Libman-Sacks endocarditis in systemic Lupus Erythematosus: Prevalence, associations, and evolution. Am J Med. 2007;120(7):636\u201342. https:\/\/doi.org\/10.1016\/j.amjmed.2007.01.024.","journal-title":"Am J Med"},{"issue":"5","key":"2121_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/0735-1097(92)90368-w","volume":"20","author":"CA Roldan","year":"1992","unstructured":"Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992;20(5):1127\u201334. https:\/\/doi.org\/10.1016\/0735-1097(92)90368-w.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2121_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s0002-9343(88)80236-5","volume":"85","author":"KV Straaton","year":"1988","unstructured":"Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med. 1988;85(5):645\u201350. https:\/\/doi.org\/10.1016\/s0002-9343(88)80236-5.","journal-title":"Am J Med"},{"issue":"19","key":"2121_CR24","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1056\/NEJM199611073351903","volume":"335","author":"CA Roldan","year":"1996","unstructured":"Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335(19):1424\u201330. https:\/\/doi.org\/10.1056\/NEJM199611073351903.","journal-title":"N Engl J Med"},{"key":"2121_CR25","doi-asserted-by":"publisher","unstructured":"Hussain K, Gauto-Mariotti E, Cattoni HM, Arif AW, Richardson C, Manadan A, Yadav N. A Meta-analysis and Systematic Review of Valvular Heart Disease in Systemic Lupus Erythematosus and Its Association with Antiphospholipid Antibodies. J Clin Rheumatol. 2021;27(8):e525-e532. https:\/\/doi.org\/10.1097\/RHU.0000000000001464.","DOI":"10.1097\/RHU.0000000000001464"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02121-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:15:29Z","timestamp":1730805329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02121-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02121-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"16 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Dr. Al-Zahir has nothing to disclose. Dr. Chan reports being on the Data Safety Monitoring Board of two trials (COPAS and EVOID-AS). COPAS is a pilot study initiated locally testing the effect of colchicine on progression of aortic stenosis, and EVOID-AS is a multi- center multinational study on the progression of aortic stenosis. He also reports being a member of task force on echo accreditation, Accreditation Canada and being a member of Cardiogenetics Expert Group, Ministry of Health, province of Ontario.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}